• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How SOLID is the immune system's response to the deadly duo of lung cancer and SARS-CoV-2?

作者信息

Narvel Hiba, Halmos Balazs

机构信息

Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Transl Lung Cancer Res. 2022 Feb;11(2):126-131. doi: 10.21037/tlcr-22-130.

DOI:10.21037/tlcr-22-130
PMID:35280321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8902086/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7503/8902086/5b9895229d91/tlcr-11-02-126-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7503/8902086/5b9895229d91/tlcr-11-02-126-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7503/8902086/5b9895229d91/tlcr-11-02-126-f1.jpg

相似文献

1
How SOLID is the immune system's response to the deadly duo of lung cancer and SARS-CoV-2?免疫系统对肺癌和新冠病毒这一致命组合的反应有多可靠？
Transl Lung Cancer Res. 2022 Feb;11(2):126-131. doi: 10.21037/tlcr-22-130.
2
Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.新型冠状病毒免疫病理学中低度炎症的意义。
MEDICC Rev. 2021 Apr;23(2):42. doi: 10.37757/MR2021.V23.N2.4. Epub 2021 Apr 30.
3
Patients' and health system's delays in the diagnosis and treatment of new pulmonary tuberculosis patients in West Gojjam Zone, Northwest Ethiopia: a cross-sectional study.埃塞俄比亚西北部戈贾姆西区新肺结核患者的诊断和治疗中患者及卫生系统的延误：一项横断面研究
BMC Infect Dis. 2016 Nov 11;16(1):673. doi: 10.1186/s12879-016-1995-z.
4
A feasibility study for high-resolution silicon array detector performance in the magnetic field of a permanent magnet system.高分辨率硅阵列探测器在永磁体系统磁场中的性能可行性研究。
Med Phys. 2019 Sep;46(9):4224-4232. doi: 10.1002/mp.13686. Epub 2019 Jul 12.
5
Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的奥密克戎变种（B.1.1.529）：突变、传染性、传播及疫苗抗性
World J Clin Cases. 2022 Jan 7;10(1):1-11. doi: 10.12998/wjcc.v10.i1.1.
6
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.肺癌患者中针对严重急性呼吸综合征冠状病毒2的血清流行率和免疫记忆：SOLID研究
Transl Lung Cancer Res. 2022 Jan;11(1):53-63. doi: 10.21037/tlcr-21-504.
7
Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.评价两种 SARS-CoV-2 快速 IgM-IgG 联合抗体检测试剂盒在指尖毛细血管全血样本中的性能。
PLoS One. 2020 Sep 17;15(9):e0237694. doi: 10.1371/journal.pone.0237694. eCollection 2020.
8
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.SARS-CoV-2 激活肺上皮细胞促炎信号，导致 COVID-19 患者免疫失调。
EBioMedicine. 2021 Aug;70:103500. doi: 10.1016/j.ebiom.2021.103500. Epub 2021 Jul 23.
9
A Health Care System's Approach to Support Nursing Leaders in Mitigating Burnout Amid a COVID-19 World Pandemic.医疗体系支持护理领导者应对 COVID-19 大流行期间职业倦怠的方法。
Nurs Adm Q. 2022;46(1):52-59. doi: 10.1097/NAQ.0000000000000507.
10
Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19.间充质干细胞过表达MAVS蛋白的靶向线粒体治疗：一种针对COVID-19的新治疗方法。
Front Cell Dev Biol. 2021 Jun 11;9:695362. doi: 10.3389/fcell.2021.695362. eCollection 2021.

本文引用的文献

1
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.肺癌患者中针对严重急性呼吸综合征冠状病毒2的血清流行率和免疫记忆：SOLID研究
Transl Lung Cancer Res. 2022 Jan;11(1):53-63. doi: 10.21037/tlcr-21-504.
2
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.2019 冠状病毒病诊断的胸部恶性肿瘤患者的明确预后系统：TERAVOLT 登记处的更新。
J Thorac Oncol. 2022 May;17(5):661-674. doi: 10.1016/j.jtho.2021.12.015. Epub 2022 Feb 1.
3
COVID-19 vaccination and breakthrough infections in patients with cancer.
COVID-19 疫苗接种和癌症患者的突破性感染。
Ann Oncol. 2022 Mar;33(3):340-346. doi: 10.1016/j.annonc.2021.12.006. Epub 2021 Dec 24.
4
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.假型 SARS-CoV-2 变异株奥密克戎的显著免疫逃逸。
Emerg Microbes Infect. 2022 Dec;11(1):1-5. doi: 10.1080/22221751.2021.2017757.
5
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.严重急性呼吸综合征冠状病毒 2 疫苗在胸部癌症患者中的疗效：一项支持在两剂疫苗接种后血清学应答轻微的患者中接种第三剂疫苗的前瞻性研究。
J Thorac Oncol. 2022 Feb;17(2):239-251. doi: 10.1016/j.jtho.2021.10.015. Epub 2021 Nov 16.
6
Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center.德国大学肿瘤中心癌症患者中 SARS-CoV-2 抗体血清学阳性率较低。
Oncol Res Treat. 2022;45(3):112-117. doi: 10.1159/000520572. Epub 2021 Nov 1.
7
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients.接受积极治疗的癌症患者中 BNT162b2 mRNA COVID-19 疫苗的免疫原性和安全性。
J Natl Cancer Inst. 2022 Feb 7;114(2):203-209. doi: 10.1093/jnci/djab174.
8
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.英国普通人群中 45965 名成年人对 SARS-CoV-2 疫苗的抗体反应。
Nat Microbiol. 2021 Sep;6(9):1140-1149. doi: 10.1038/s41564-021-00947-3. Epub 2021 Jul 21.
9
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.mRNA 疫苗在癌症患者中的免疫原性。
Cancer Cell. 2021 Aug 9;39(8):1091-1098.e2. doi: 10.1016/j.ccell.2021.06.009. Epub 2021 Jun 18.
10
Seroconversion rates following COVID-19 vaccination among patients with cancer.癌症患者接种 COVID-19 疫苗后的血清转化率。
Cancer Cell. 2021 Aug 9;39(8):1081-1090.e2. doi: 10.1016/j.ccell.2021.06.002. Epub 2021 Jun 5.